https://doctransparency.com/doctor/tx/houston/joseph-galati-1821069162
Medicare Enrolled

Dr. Joseph Galati, M.D.

Hepatology Physician · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
1200 BINZ ST STE 850, Houston, TX 77004
7137940700
In practice since 2006 (20 years)
NPI: 1821069162 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Galati from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Galati? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Galati

Dr. Joseph Galati is a hepatology physician in Houston, TX, with 20 years in practice. Based on federal Medicare data, Dr. Galati performed 3,947 Medicare services across 2,078 unique beneficiaries.

Between the years covered by Open Payments, Dr. Galati received a total of $188,383 from 38 pharmaceutical and/or device companies across 742 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hepatology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Galati is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 9% volume in TX$ $188,383 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,947
Medicare services
Top 9% in TX for hepatology physician
2,078
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~197 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)843$94$220
Office visit, established patient, complex (40-54 min)797$131$296
Hospital follow-up visit, high complexity746$95$215
Complete ultrasound scan of abdomen305$93$253
Complete ultrasound of abdomen and pelvis artery and vein blood flow299$192$578
Critical care, first 30-74 min256$173$563
Initial hospital admission, high complexity170$135$417
Measurement of liver stiffness165$23$70
New patient office visit (45-59 min)106$120$336
New patient office visit, complex (60-74 min)77$154$422
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope67$84$528
Upper GI endoscopy with biopsy38$96$705
Colonoscopy with biopsy29$99$834
Removal of polyps or growths of large bowel using an endoscope with mechanical snare18$204$876
Colorectal cancer screening; colonoscopy on individual at high risk17$186$418
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk14$186$419
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$188,383
Total received (2018-2024)
Avg $26,912/year across 7 years
Top 20% in TX for hepatology physician
38
Companies
742
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$180,384 (95.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,876 (3.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,123 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$39,779
2023
$53,410
2022
$49,616
2021
$7,260
2020
$15,468
2019
$5,708
2018
$17,143

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$61,619
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$57,894
INTERCEPT PHARMACEUTICALS, INC.
$38,682
Intercept Pharmaceuticals, Inc.
$20,510
Madrigal Pharmaceuticals
$5,558
ABBVIE INC.
$823
AbbVie, Inc.
$478
INTRA-SANA LABORATORIES
$369
AbbVie Inc.
$244
Perspectum Diagnostics Ltd
$233
Ipsen Biopharmaceuticals, Inc
$222
Novo Nordisk Inc
$221
Shionogi Inc
$204
FUJIFILM Healthcare Americas Corporation
$187
Takeda Pharmaceuticals U.S.A., Inc.
$135
Ferring Pharmaceuticals Inc.
$129
Dova Pharmaceuticals
$123
Mallinckrodt Hospital Products Inc.
$122
ORPHALAN INC
$115
ALBIREO PHARMA, INC.
$103
Eisai Inc.
$43
Ardelyx, Inc.
$37
Olympus America Inc.
$36
Ultragenyx Pharmaceutical Inc.
$35
Bayer HealthCare Pharmaceuticals Inc.
$32
AstraZeneca Pharmaceuticals LP
$24
Teleflex LLC
$23
Ironwood Pharmaceuticals, Inc
$22
Merck Sharp & Dohme LLC
$20
VBI Vaccine (Delaware) Inc.
$19
Exact Sciences Corporation
$19
Vifor Pharma, Inc.
$18
Alexion Pharmaceuticals, Inc.
$18
Merck Sharp & Dohme Corporation
$15
Braintree Laboratories, Inc.
$14
Prometheus Laboratories Inc.
$14
Allergan Inc.
$12
Synergy Pharmaceuticals Inc
$11
Top 3 companies account for 84.0% of total payments
Associated products mentioned in payments ›
APRISO · AVYCAZ · Bylvay · CLENPIQ · CREON · CUVRIOR · Creon · Doptelet · ENTYVIO · Epclusa · IBSRELA · IQIRVO · KEYTRUDA · Kanuma · LINZESS · Lenvima · LiverMultiScan · MAVYRET · Mavyret · Mulpleta · Nexavar · OCALIVA · Olympus Biliary Devices · Olympus EUS Devices · PreHevbrio · QuikClot · REBYOTA · RELISTOR · RELISTOR ORAL · RELTONE 200 MG · RESMETIROM · REZDIFFRA · SUPREP · Saxenda · TEFLARO · TERLIVAZ · TRULANCE · Trulance · UCERIS · UTASWAKO AFP-L3 · VIBERZI · Veltassa · Wegovy · XIFAXAN · XIFIXAN · uTASWako AFP-L3
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hepatology physician and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $4,773 per 100 Medicare services performed
Looking for a hepatology physician in Houston?
Compare hepatology physicians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse hepatology physicians nearby

Geographic Context

Hepatology Physicians within 10 mi
5
Per 100K population
0.1
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Galati is a clinical cardiology specialist, with above-average Medicare volume (top 9% in TX), and high industry engagement (speaking/promotional, top 20%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Galati experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Galati performed 843 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Galati receive payments from pharmaceutical companies?
Yes. Dr. Galati received a total of $188,383 from 38 companies across 742 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Galati's costs compare to other hepatology physicians in Houston?
Dr. Galati's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Galati) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →